TP53 and hepatocellular carcinoma: A recent study suggested mononuclear polyploidy as marker for HCC aggressiveness, as in this cohort patients with highly polyploid, and often p53‐mutated tumors, have an increased risk for recurrence (Bou‐Nader et al, 2019).